Status:
COMPLETED
Retrospective Multicenter Clinical Evaluation of Complications for Single or Multilevel VEO® Lateral Access and Interbody Fusion System and eXtreme Lateral Interbody Fusion (XLIF®) Subjects
Lead Sponsor:
Baxano Surgical, Inc.
Conditions:
Degenerative Disc Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this retrospective clinical evaluation is to compare VEO® single or multilevel results to XLIF® single or multilevel results relative to the safety endpoints. This study will collect re...
Eligibility Criteria
Inclusion
- Adult 18 years of age or older;
- Male or female VEO® subjects that had previously received the single or two level LLIF procedure using the VEO® or XLIF® systems as an adjunct to fusion at L2-S1 to treat degenerative disc disease (DDD) at the treated level;
- Subject that was treated no less than 3 months prior to this evaluation with the LLIF procedure using the VEO® or XLIF® system by the participating surgeons.
Exclusion
- Subject who did not receive LLIF procedure using the VEO® or XLIF® system for fusion of L2-S1;
- Subjects with less than 3 months of follow-up data.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT01878149
Start Date
June 1 2013
End Date
March 1 2014
Last Update
August 12 2014
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Orthopaedic Surgical Group
Long Beach, California, United States, 90806
2
Minimally Invasive Neurosurgery
Santa Ana, California, United States, 92705
3
NorthShore LIJ
Great Neck, New York, United States, 11021
4
Advanced Spine & Pain
Arlington, Virginia, United States, 22205